Genoil Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Genoil Inc. (GNOLF) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $1.57 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-01.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-05-01
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|
| 2024-12-31 | $1.57K 20-F · filed 2025-05-01 |
| 2023-12-31 | $5.42K 20-F · filed 2025-05-01 |
| 2022-12-31 | $5.03K 20-F/A · filed 2024-05-16 |
| 2021-12-31 | -$3.38K 20-F/A · filed 2024-05-16 |
| 2020-12-31 | $2.03K 20-F · filed 2023-05-02 |